Goldman Sachs
FURX

Goldman Sachs’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Goldman Sachs’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,229
Closed -$1.72M – 7507
2014
Q2 		$1.72M Buy
16,229
+8,891
+121% +$872K ﹤0.01% 4147
2014
Q1 		$638K Sell
7,338
-9,977
-58% -$770K ﹤0.01% 5061
2013
Q4 		$727K Buy
17,315
+8,526
+97% +$351K ﹤0.01% 5014
2013
Q3 		$387K Sell
8,789
-3,751
-30% -$155K ﹤0.01% 5355
2013
Q2 		$427K Buy
+12,540
New +$440K ﹤0.01% 5063

Goldman Sachs's FURX Position: Q3 2014 in Review

Goldman Sachs sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 16,229 shares — an estimated $1.72M sold.

Goldman Sachs first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $1.72M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Goldman Sachs reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Goldman Sachs sold 16,229 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $1.72M.
  • Goldman Sachs first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Goldman Sachs's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.72M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Goldman Sachs's 13F filing for Q3 2014, filed 14 Nov 2014.